Deciphera Pharmaceuticals Inc (DCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 64,741 | 82,538 | 109,698 | 95,332 | 87,063 |
| Marketable Securities | 259,745 | 282,039 | 274,149 | 161,221 | 198,571 |
| Receivables | 22,429 | 23,278 | 25,851 | 23,151 | 20,595 |
| Inventories | 20,561 | 19,129 | 20,889 | 19,627 | 14,125 |
| TOTAL | $392,958 | $420,879 | $448,531 | $319,835 | $339,014 |
| Non-Current Assets | |||||
| PPE Net | 6,707 | 7,152 | 7,353 | 7,821 | 8,610 |
| Investments And Advances | 17,827 | 10,282 | 12,477 | 21,962 | 45,060 |
| Other Non-Current Assets | 36,547 | 37,639 | 38,676 | 35,846 | 36,800 |
| TOTAL | $61,081 | $55,073 | $58,506 | $65,629 | $90,470 |
| Total Assets | $454,039 | $475,952 | $507,037 | $385,464 | $429,484 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,612 | 12,800 | 16,229 | 17,801 | 13,130 |
| Accrued Expenses | 64,622 | 59,498 | 55,214 | 65,938 | 80,773 |
| TOTAL | $86,469 | $75,468 | $74,545 | $86,670 | $96,773 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 25,879 | 26,708 | 27,481 | 27,229 | 27,991 |
| TOTAL | $25,879 | $26,708 | $27,481 | $27,229 | $27,991 |
| Total Liabilities | $112,348 | $102,176 | $102,026 | $113,899 | $124,764 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,947 | 67,576 | 66,822 | 66,217 | 58,552 |
| Common Shares | 676 | 674 | 668 | 586 | 585 |
| Retained earnings | -1,233,363 | -1,187,428 | -1,144,385 | -1,101,324 | -1,054,432 |
| Other shareholders' equity | -983 | -2,042 | -1,268 | -563 | 51 |
| TOTAL | $341,691 | $373,776 | $405,011 | $271,565 | $304,720 |
| Total Liabilities And Equity | $454,039 | $475,952 | $507,037 | $385,464 | $429,484 |